# FDA Inspection 1229004 - BLS Labs, LLC - February 09, 2024

Source: https://www.keypedia.com/records/fda_inspections/bls-labs-llc/7eb4579e-5156-480b-b8fb-d44d6f7b5610
Source feed: FDA_Inspections

> FDA Inspection 1229004 for BLS Labs, LLC on February 09, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229004
- Company Name: BLS Labs, LLC
- Inspection Date: 2024-02-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1152160 - 2021-09-03](https://www.keypedia.com/records/fda_inspections/bls-labs-llc/f7ecefba-945a-401b-8d38-214024906b68)
- [FDA Inspection 1152160 - 2021-09-03](https://www.keypedia.com/records/fda_inspections/bls-labs-llc/75d463ed-c29d-4d73-858a-605b811af3a2)
- [FDA Inspection 1086867 - 2019-04-11](https://www.keypedia.com/records/fda_inspections/bls-labs-llc/b8e651ca-06c8-4243-9ed9-9b749884440c)

Company: https://www.keypedia.com/companies/bls-labs-llc/96a49dca-73cf-4aa8-8443-bcfb55458d28

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d